Bleeding and Platelet Disorders
Gene: JAK2
PMID 41053421: three individuals with germline c.1691 G > A, p.Arg564Gln (R564Q) gain-of-function variant and thrombocytosis.
PMID 39657124: Reports 12 individuals from 10 families with heterozygous germline JAK2 p.R564Q/L variants presenting with hereditary thrombocythemia (HT) and variable predisposition to myeloproliferative neoplasms (ET, PV) and lymphoid malignancies (CLL, AML, MGUS).
PMID 39323414: Reports 8 individuals from a single family with heterozygous germline JAK2 F556V gain‑of‑function variants presenting with familial thrombocytosis (hereditary thrombocythemia).
Overall, sufficient cases with germline variants for GREEN rating.Created: 26 May 2026, 12:06 p.m.
Thrombocythemia: original family reported with missense variant in PMID 22397670. Variant is present in gnomad in 97 individuals (March 2022). Another individual reported with variant at same residue PMID 35129130.
Somatic variants in this gene are well established as contributing a range of haematological phenotypes, including erythrocytosis, myelofibrosis, polycythaemia rubra vera, AML.Created: 7 Mar 2022, 9:16 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Thrombocythaemia 3, MIM# 614521
Publications
gene: JAK2 was added gene: JAK2 was added to Bleeding and Platelet Disorders. Sources: Expert Review Green,Victorian Clinical Genetics Services somatic tags were added to gene: JAK2. Mode of inheritance for gene: JAK2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: JAK2 were set to 22397670; 35129130; 41053421; 39657124; 39323414 Phenotypes for gene: JAK2 were set to Thrombocythaemia 3, MIM# 614521